BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1661303)

  • 1. Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma.
    Wyatt DE; Coyle PV
    J Clin Pathol; 1991 Nov; 44(11):966. PubMed ID: 1661303
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent polyclonal B lymphocytosis with Epstein-Barr virus antibodies and subsequent malignant pulmonary blastoma.
    Lawlor E; Murray M; O'Briain DS; Blaney C; Foroni L; Sarsfield P; Condell D; Sullivan F; McCann SR
    J Clin Pathol; 1991 Apr; 44(4):341-2. PubMed ID: 1851502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific IgM response and characteristics of the lymphoblastoid cell lines obtained from an infant with probable mixed cytomegalovirus and Epstein-Barr virus infection.
    Joncas JH; Menezes J; Lussier G
    IARC Sci Publ (1971); 1975; (11 Pt 2):283-9. PubMed ID: 191372
    [No Abstract]   [Full Text] [Related]  

  • 4. Persistent polyclonal B-cell lymphocytosis.
    Ide L; Dekoninck A; Verburgh E; Goossens W; Brusselmans C; Boeckx N; Emonds MP; Vandekerckhove P
    Acta Clin Belg; 2002; 57(1):31-3. PubMed ID: 12017755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr Virus Lytic Reactivation Induces IgG4 Production by Host B Lymphocytes in Graves' Disease Patients and Controls: A Subset of Graves' Disease Is an IgG4-Related Disease-Like Condition.
    Nagata K; Hara S; Nakayama Y; Higaki K; Sugihara H; Kuwamoto S; Matsushita M; Kato M; Tanio S; Ishiguro K; Hayashi K
    Viral Immunol; 2018 Oct; 31(8):540-547. PubMed ID: 30222515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent polyclonal lymphocytosis of B lymphocytes.
    Gordon DS; Jones BM; Browning SW; Spira TJ; Lawrence DN
    N Engl J Med; 1982 Jul; 307(4):232-6. PubMed ID: 6979709
    [No Abstract]   [Full Text] [Related]  

  • 7. Stabilizing antibody secretion of human Epstein Barr virus-activated B-lymphocytes with hybridoma formation by electrofusion.
    Perkins S; Foung SK
    Methods Mol Biol; 1995; 48():295-307. PubMed ID: 8528401
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.
    Hudnall SD; Patel J; Schwab H; Martinez J
    Cytometry B Clin Cytom; 2003 Sep; 55(1):22-8. PubMed ID: 12949956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus in rheumatoid arthritis.
    Fox RI; Lotz M; Rhodes G; Vaughan JH
    Clin Rheum Dis; 1985 Dec; 11(3):665-88. PubMed ID: 3000687
    [No Abstract]   [Full Text] [Related]  

  • 10. A study on the relation between the Epstein-Barr virus and some forms of malignant tumors in children.
    Gourtsevicz VE; Stepina VN; Mazurenko NP; Durnov LA; Yarymova NM; Yermakov YS
    Neoplasma; 1976; 23(5):533-9. PubMed ID: 185536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C; Hofmann J; Ruprecht K
    Med Hypotheses; 2016 Jun; 91():109-113. PubMed ID: 27142157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus specific antibodies in patients with IgA nephropathy.
    Wu AY; Lau YK; Chia KB; Lim CH
    Singapore Med J; 1988 Jun; 29(3):257-60. PubMed ID: 2847323
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined automated cell and flow cytometric analysis enables recognition of persistent polyclonal B-cell lymphocytosis (PPBL), a study of 25 patients.
    Schmidt-Hieber M; Burmeister T; Weimann A; Nagorsen D; Hofmann WK; Thiel E; Schwartz S
    Ann Hematol; 2008 Oct; 87(10):829-36. PubMed ID: 18587574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgM interference in determination of antiphospholipid antibodies and erythrocyte sedimentation rate in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.
    Lesesve JF; Devignes J; Sokolowska J; Aimone-Gastin I; Jacob C; Wahl D; Troussard X; Lecompte T
    Int J Lab Hematol; 2011 Oct; 33(5):e9-11. PubMed ID: 21435190
    [No Abstract]   [Full Text] [Related]  

  • 15. Diffuse polyclonal B-cell lymphoma during primary infection with Epstein-Barr virus.
    Robinson JE; Brown N; Andiman W; Halliday K; Francke U; Robert MF; Andersson-Anvret M; Horstmann D; Miller G
    N Engl J Med; 1980 Jun; 302(23):1293-7. PubMed ID: 6245364
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyclonal B-cell lymphoma during infection with Epstein-Barr virus.
    Wright DH
    N Engl J Med; 1980 Oct; 303(18):1064-5. PubMed ID: 6252464
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S; Nakamura S; Yamamoto K; Miyauchi H; Kagami Y; Kinoshita T; Onoda H; Yatabe Y; Ito M; Miyamura K; Nagai H; Moritani S; Sugiura I; Tsushita K; Mihara H; Ohbayashi K; Iba S; Emi N; Okamoto M; Iwata S; Kimura H; Kuzushima K; Morishima Y
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-phospholipid/cofactor antibodies in three cases of persistent polyclonal B lymphocytosis.
    Granel B; Serratrice J; Disdier P; SanMarco M; Hubert MM; Alessi MC; Cannoni H; Camoin L; Bouabdallah R; Juhan-Vague I; Weiller PJ
    Br J Haematol; 2002 Dec; 119(3):875-6. PubMed ID: 12437675
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune responses to Epstein-Barr virus in atomic bomb survivors: study of precursor frequency of cytotoxic lymphocytes and titer levels of anti-Epstein-Barr virus-related antibodies.
    Kusunoki Y; Kyoizumi S; Fukuda Y; Huang H; Saito M; Ozaki K; Hirai Y; Akiyama M
    Radiat Res; 1994 Apr; 138(1):127-32. PubMed ID: 8146292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The determination of the level of antibodies to Epstein-Barr virus antigens in organizing groups at high risk for lung cancer disease].
    Zyrianov BN; Podoplekin VD; Siianov VS; Kuznetsova TI; Tuzikov SA
    Vopr Onkol; 1990; 36(5):545-9. PubMed ID: 2165702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.